CRISPR Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results – GlobeNewswire (press release)
Post Analyst |
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results
GlobeNewswire (press release) ZUG, Switzerland and CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today provided a business update and … Investors Jumping Ship on Skechers USA, Inc. (SKX), CRISPR Therapeutics AG (CRSP)Post Analyst The Market’s 4 Best Stocks to Buy Right NowYahoo Finance |
Genetic Literacy Project |
Synthetic biology’s ‘promise and potential’ capture investor attention
Genetic Literacy Project Synthetic Biology has become the new frontier of genetic engineering, promising to radically change the way we make clothes, fragrances, flavors, biofuels and plastics. Utilizing yeast, algae, microbes and bacteria as tiny manufacturing plants, it may … |
Genetic Literacy Project |
Synthetic biology’s ‘promise and potential’ capture investor attention
Genetic Literacy Project Utilizing yeast, algae, microbes and bacteria as tiny manufacturing plants, it may help us produce meatless meat, non-animal leather and even clean up oil spills. We could find our way to greater sustainability by replacing plastics, metals and wood … |
Positive Newspaper |
Stem Cells in Drug Discovery & Toxicity Screening Conference 2018 (San Diego, CA, United States – October 4th-5th …
GlobeNewswire (press release) Dublin, May 08, 2018 (GLOBE NEWSWIRE) — The “Stem Cells in Drug Discovery & Toxicity Screening 2018″ conference has been added to ResearchAndMarkets.com’s offering. Stem Cells in Drug Discovery, and Toxicity Screening 2018 brings together researchers … Stem Cell Assay Market to Surge at a Robust Pace by 2024Digital Journal Canine Stem Cell Therapy Market to hike at 4.2% CAGR During 2017-2026Technical Progress |